Emerging treatments for soft tissue sarcoma of adults.

about

Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.

P2860

Q37038352-73318E75-7794-44C3-B04D-271B5864C3B0

P2860

Emerging treatments for soft tissue sarcoma of adults.

Item

http://www.wikidata.org/entity/Q35967402

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Emerging treatments for soft tissue sarcoma of adults.

@ast

Emerging treatments for soft tissue sarcoma of adults.

@en

type

Item

label

Emerging treatments for soft tissue sarcoma of adults.

@ast

Emerging treatments for soft tissue sarcoma of adults.

@en

prefLabel

Emerging treatments for soft tissue sarcoma of adults.

@ast

Emerging treatments for soft tissue sarcoma of adults.

@en

P1476

Emerging treatments for soft tissue sarcoma of adults.

@en

P2093

Rolf D Issels

http://www.w3.org/2001/XMLSchema#string

Werner Fahn

http://www.w3.org/2001/XMLSchema#string

P2860

Should tumor depth be included in prognostication of soft tissue sarcoma?

Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.

Current uses of isolated limb perfusion in the clinic and a model system for new strategies.

Isolated limb perfusion in the management of locally advanced extremity soft tissue sarcoma.

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults.

Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Phase II trial of gemcitabine in advanced sarcomas.

Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcoma.

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma.

P304

313-334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.9.2.313

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15571488

http://www.w3.org/2001/XMLSchema#string

Emerging treatments for soft tissue sarcoma of adults.

about

P2860

P2860

Emerging treatments for soft tissue sarcoma of adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698